Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer

Philip Q. Bao, Ramesh K. Ramanathan, Alyssa Krasinkas, Nathan Bahary, Barry C. Lembersky, David L. Bartlett, Steven J. Hughes, Kenneth K. Lee, A. James Moser, Herbert J. Zeh

Research output: Contribution to journal › Article › peer-review